"Humanity is not defined by our abilities, but by our capacity to care, connect, and create positive change."
Established in 2015, GRAPPER & GRISLEY is a leading pharmaceutical company committed to delivering high-quality, research-driven healthcare solutions. Operating through WHO-GMP certified manufacturing units, we have earned a reputation as a trusted manufacturer and supplier of pharmaceutical products globally.
We export our pharmaceutical formulations to various countries, including East Timor, Canada, France, Somalia, Venezuela, Cambodia, Nigeria, Angola, Chile, and Kyrgyzstan. Our commitment to quality, transparency, and competitiveness fosters strong, long-term global partnerships.
Under the leadership of Mr. V. Garg, an industry veteran with vast experience in domestic and international markets, GRAPPER & GRISLEY thrives in generic formulations. His strategic vision drives our mission of providing affordable healthcare solutions worldwide.
Our state-of-the-art manufacturing facilities in Amritsar, Uttarakhand, Haridwar, Haryana, Hyderabad, and Himachal Pradesh (Baddi) comply with WHO-GMP standards. We uphold strict quality control measures to ensure the highest safety and efficacy of our pharmaceutical products.
We are a technology-driven company with a research-oriented approach focused on improving patient outcomes. Our R&D division specializes in Formulation Development, Bioequivalence (B.E) Studies, Clinical Trials, and Regulatory Approvals.
At GRAPPER & GRISLEY, we believe in transforming healthcare through creativity, technology, and strategic planning. Our mission is to provide high-quality, affordable pharmaceutical solutions, lead innovation in healthcare products, and uphold ethical values while contributing to society.
Normal Human Albumin 20% is a non-pyrogenic, sterile aqueous solution of human albumin for intravenous administration and is purified from pooled human plasma using a series of chromatography steps.
Human albumin is produced from pooled human plasma for fractionation conforming to the highest standards set forth by regulatory authorities. To improve the margin of safety, effective viral inactivation steps have been integrated into the manufacturing and formulation process. The final product is tested to ensure freedom from viruses like HIV, HBV, and HCV.
Indications |
Hypovolemic Shock
Burns Hypoproteinemia Hemorrhagic Shock Ascites |
---|---|
Storage |
Store between 2°C to 25°C.
Do not freeze. Protect from light. |
Shelf-Life | 36 months from the date of manufacture. |
10 g in 50 mL infusion bottle |
20 g in 100 mL infusion bottle |